Matthew R. Kwietniak is Chief Commercial Officer of Avid Bioservices, Inc.. Currently has a direct ownership of 25,407 shares of CDMO, which is worth approximately $311,489. The most recent transaction as insider was on Oct 14, 2024, when has been sold 119 shares (Common Stock, $0.001 par value) at a price of $10.15 per share, resulting in proceeds of $1,207. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.4K
8.53% 3M change
41.46% 12M change
Total Value Held $311,489

Matthew R. Kwietniak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 14 2024
SELL
Open market or private sale
$1,207 $10.15 p/Share
119 Reduced 0.47%
25,407 Common Stock, $0.001 p...
Oct 11 2024
BUY
Exercise of conversion of derivative security
-
335 Added 1.3%
25,526 Common Stock, $0.001 p...
Oct 10 2024
SELL
Open market or private sale
$9,869 $10.05 p/Share
982 Reduced 3.75%
25,191 Common Stock, $0.001 p...
Oct 09 2024
BUY
Exercise of conversion of derivative security
-
2,763 Added 9.55%
26,173 Common Stock, $0.001 p...
Jul 15 2024
SELL
Open market or private sale
$2,566 $8.36 p/Share
307 Reduced 1.29%
23,410 Common Stock, $0.001 p...
Jul 12 2024
SELL
Open market or private sale
$957 $8.05 p/Share
119 Reduced 0.52%
22,836 Common Stock, $0.001 p...
Jul 12 2024
BUY
Exercise of conversion of derivative security
-
881 Added 3.58%
23,717 Common Stock, $0.001 p...
Jul 11 2024
BUY
Exercise of conversion of derivative security
-
335 Added 1.44%
22,955 Common Stock, $0.001 p...
Jul 10 2024
SELL
Open market or private sale
$3,347 $7.54 p/Share
444 Reduced 1.93%
22,620 Common Stock, $0.001 p...
Jul 09 2024
BUY
Exercise of conversion of derivative security
-
1,267 Added 5.21%
23,064 Common Stock, $0.001 p...
Apr 30 2024
SELL
Open market or private sale
$9,124 $7.4 p/Share
1,233 Reduced 5.35%
21,797 Common Stock, $0.001 p...
Apr 11 2024
BUY
Exercise of conversion of derivative security
-
669 Added 2.82%
23,030 Common Stock, $0.001 p...
Apr 09 2024
BUY
Exercise of conversion of derivative security
-
2,532 Added 10.17%
22,361 Common Stock, $0.001 p...
Jan 12 2024
SELL
Open market or private sale
$1,854 $6.77 p/Share
274 Reduced 1.36%
19,829 Common Stock, $0.001 p...
Jan 11 2024
BUY
Exercise of conversion of derivative security
-
669 Added 3.22%
20,103 Common Stock, $0.001 p...
Jan 10 2024
SELL
Open market or private sale
$6,540 $6.17 p/Share
1,060 Reduced 5.17%
19,434 Common Stock, $0.001 p...
Jan 09 2024
BUY
Exercise of conversion of derivative security
-
2,533 Added 11.0%
20,494 Common Stock, $0.001 p...
Oct 12 2023
SELL
Open market or private sale
$2,343 $9.19 p/Share
255 Reduced 1.4%
17,961 Common Stock, $0.001 p...
Oct 11 2023
BUY
Exercise of conversion of derivative security
-
670 Added 3.55%
18,216 Common Stock, $0.001 p...
Oct 10 2023
SELL
Open market or private sale
$8,924 $9.2 p/Share
970 Reduced 5.24%
17,546 Common Stock, $0.001 p...
Oct 09 2023
BUY
Exercise of conversion of derivative security
-
2,532 Added 12.03%
18,516 Common Stock, $0.001 p...
Jul 12 2023
SELL
Open market or private sale
$3,429 $13.61 p/Share
252 Reduced 1.55%
15,984 Common Stock, $0.001 p...
Jul 11 2023
BUY
Exercise of conversion of derivative security
-
669 Added 3.96%
16,236 Common Stock, $0.001 p...
Jul 10 2023
SELL
Open market or private sale
$6,568 $13.77 p/Share
477 Reduced 2.97%
15,567 Common Stock, $0.001 p...
Jul 09 2023
BUY
Exercise of conversion of derivative security
-
1,261 Added 7.29%
16,044 Common Stock, $0.001 p...
MRK

Matthew R. Kwietniak

Chief Commercial Officer
Tustin, CA

Track Institutional and Insider Activities on CDMO

Follow Avid Bioservices, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDMO shares.

Notify only if

Insider Trading

Get notified when an Avid Bioservices, Inc. insider buys or sells CDMO shares.

Notify only if

News

Receive news related to Avid Bioservices, Inc.

Track Activities on CDMO